Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 3631 AL 3645

Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease

Quinn L, Playle R, Drew CJG, Taiyari K, Williams-Thomas R, Muratori LM, Hamana K, Griffin BA, Kelson M, Schubert R, Friel C, Morgan-Jones P, Rosser A, Busse M; PACE-HD site investigators.

Parkinsonism Relat Disord. 2022 Aug;101:75-89. doi: 10.1016/j.parkreldis.2022.06.013. Epub 2022 Jun 29.

The Role of DNA Damage in Neural Plasticity in Physiology and Neurodegeneration

Konopka A, Atkin JD.

Front Cell Neurosci. 2022 Jun 23;16:836885. doi: 10.3389/fncel.2022.836885. eCollection 2022.

The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review

Li KR, Wu AG, Tang Y, He XP, Yu CL, Wu JM, Hu GQ, Yu L.

Mol Neurobiol. 2022 Oct;59(10):5935-5954. doi: 10.1007/s12035-022-02944-x. Epub 2022 Jul 12.

Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases

Sun Y, Xia X, Basnet D, Zheng JC, Huang J, Liu J.

Front Aging Neurosci. 2022 Jun 28;14:904152. doi: 10.3389/fnagi.2022.904152. eCollection 2022.

Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects

Rahbaran M, Zekiy AO, Bahramali M, Jahangir M, Mardasi M, Sakhaei D, Thangavelu L, Shomali N, Zamani M, Mohammadi A, Rahnama N.

Cell Mol Biol Lett. 2022 Jul 16;27(1):56. doi: 10.1186/s11658-022-00359-z.

Autophagy in health and disease: From molecular mechanisms to therapeutic target

Lu G, Wang Y, Shi Y, Zhang Z, Huang C, He W, Wang C, Shen HM.

MedComm (2020). 2022 Jul 10;3(3):e150. doi: 10.1002/mco2.150. eCollection 2022 Sep.

Recent Microscopy Advances and the Applications to Huntington's Disease Research

Babi M, Neuman K, Peng CY, Maiuri T, Suart CE, Truant R.

J Huntingtons Dis. 2022;11(3):269-280. doi: 10.3233/JHD-220536.

Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases

Luo M, Lee LKC, Peng B, Choi CHJ, Tong WY, Voelcker NH.

Adv Sci (Weinh). 2022 Sep;9(26):e2201740. doi: 10.1002/advs.202201740. Epub 2022 Jul 18.

Exploring the management approaches of cytokines including viral infection and neuroinflammation for neurological disorders

Mominur Rahman M, Afsana Mim S, Afroza Alam Tumpa M, Taslim Sarker M, Ahmed M, Alghamdi BS, Hafeez A, Alexiou A, Perveen A, Md Ashraf G.

Cytokine. 2022 Sep;157:155962. doi: 10.1016/j.cyto.2022.155962. Epub 2022 Jul 16.

Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review

Oikonomou P, Jost WH.

J Neural Transm (Vienna). 2022 Oct;129(10):1247-1256. doi: 10.1007/s00702-022-02529-x. Epub 2022 Jul 20.

Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration

García-Revilla J, Boza-Serrano A, Espinosa-Oliva AM, Soto MS, Deierborg T, Ruiz R, de Pablos RM, Burguillos MA, Venero JL.

Cell Death Dis. 2022 Jul 20;13(7):628. doi: 10.1038/s41419-022-05058-3.

Protective Effects of Polysaccharides in Neurodegenerative Diseases

Wang Y, Chen R, Yang Z, Wen Q, Cao X, Zhao N, Yan J.

Front Aging Neurosci. 2022 Jul 4;14:917629. doi: 10.3389/fnagi.2022.917629. eCollection 2022.

Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation

Abulseoud OA, Alasmari F, Hussein AM, Sari Y.

Front Neurosci. 2022 Jul 5;16:841036. doi: 10.3389/fnins.2022.841036. eCollection 2022.

Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats

Kaye J, Reisine T, Finkbeiner S.

Fac Rev. 2022 Jun 28;11:16. doi: 10.12703/r/11-16. eCollection 2022.

Huntingtin and Its Partner Huntingtin-Associated Protein 40: Structural and Functional Considerations in Health and Disease

Seefelder M, Klein FAC, Landwehrmeyer B, Fernández-Busnadiego R, Kochanek S.

J Huntingtons Dis. 2022;11(3):227-242. doi: 10.3233/JHD-220543.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias